| Product Code: ETC9568941 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden mRNA Therapeutics Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden mRNA Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden mRNA Therapeutics Market - Industry Life Cycle |
3.4 Sweden mRNA Therapeutics Market - Porter's Five Forces |
3.5 Sweden mRNA Therapeutics Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Sweden mRNA Therapeutics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Sweden mRNA Therapeutics Market Revenues & Volume Share, By End use, 2021 & 2031F |
4 Sweden mRNA Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investment in research and development in mRNA therapeutics technology |
4.2.2 Growing prevalence of chronic diseases in Sweden, creating a demand for innovative treatment options |
4.2.3 Supportive government initiatives and regulatory framework promoting the development and adoption of mRNA therapeutics |
4.3 Market Restraints |
4.3.1 High development costs and complex manufacturing processes associated with mRNA therapeutics |
4.3.2 Limited awareness and acceptance of mRNA therapeutics among healthcare professionals and patients in Sweden |
5 Sweden mRNA Therapeutics Market Trends |
6 Sweden mRNA Therapeutics Market, By Types |
6.1 Sweden mRNA Therapeutics Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Sweden mRNA Therapeutics Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Sweden mRNA Therapeutics Market Revenues & Volume, By Prophylactic, 2021- 2031F |
6.1.4 Sweden mRNA Therapeutics Market Revenues & Volume, By Therapeutic, 2021- 2031F |
6.2 Sweden mRNA Therapeutics Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Sweden mRNA Therapeutics Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.2.3 Sweden mRNA Therapeutics Market Revenues & Volume, By Oncology, 2021- 2031F |
6.2.4 Sweden mRNA Therapeutics Market Revenues & Volume, By Rare Genetic Diseases, 2021- 2031F |
6.2.5 Sweden mRNA Therapeutics Market Revenues & Volume, By Respiratory Diseases, 2021- 2031F |
6.2.6 Sweden mRNA Therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Sweden mRNA Therapeutics Market, By End use |
6.3.1 Overview and Analysis |
6.3.2 Sweden mRNA Therapeutics Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F |
6.3.3 Sweden mRNA Therapeutics Market Revenues & Volume, By Research Organizations, 2021- 2031F |
6.3.4 Sweden mRNA Therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
7 Sweden mRNA Therapeutics Market Import-Export Trade Statistics |
7.1 Sweden mRNA Therapeutics Market Export to Major Countries |
7.2 Sweden mRNA Therapeutics Market Imports from Major Countries |
8 Sweden mRNA Therapeutics Market Key Performance Indicators |
8.1 Number of clinical trials conducted in Sweden for mRNA therapeutics |
8.2 Rate of adoption of mRNA therapeutics in treatment protocols by healthcare facilities in Sweden |
8.3 Investment trends in mRNA therapeutics technology research and development |
8.4 Number of partnerships and collaborations between pharmaceutical companies and research institutions in Sweden for mRNA therapeutics development |
8.5 Patient outcomes and satisfaction levels with mRNA therapeutics treatments in Sweden |
9 Sweden mRNA Therapeutics Market - Opportunity Assessment |
9.1 Sweden mRNA Therapeutics Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Sweden mRNA Therapeutics Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Sweden mRNA Therapeutics Market Opportunity Assessment, By End use, 2021 & 2031F |
10 Sweden mRNA Therapeutics Market - Competitive Landscape |
10.1 Sweden mRNA Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Sweden mRNA Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here